{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:52:00Z","timestamp":1787503920750,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04465-2","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:56:33Z","timestamp":1763463393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the influence of 1% and 0.01% atropine on the corneal topography in myopic children"],"prefix":"10.1186","volume":"25","author":[{"given":"Li-Quan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Yao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Nan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"4","key":"4465_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.18240\/ijo.2021.04.19","volume":"14","author":"R Kaiti","year":"2021","unstructured":"Kaiti R, Shyangbo R, Sharma IP, Dahal M. Review on current concepts of myopia and its control strategies. Int J Ophthalmol. 2021;14(4):606\u201315.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"4465_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","volume":"33","author":"PC Wu","year":"2019","unstructured":"Wu PC, Chuang MN, Choi J, Chen H, Wu G, Ohno-Matsui K, et al. Update in myopia and treatment strategy of Atropine use in myopia control. Eye (Lond). 2019;33(1):3\u201313.","journal-title":"Eye (Lond)"},{"issue":"1","key":"4465_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et al. Low-Concentration Atropine for myopia progression (LAMP) study: A Randomized, Double-Blinded, Placebo-Controlled trial of 0.05%, 0.025%, and 0.01% Atropine eye drops in myopia control. Ophthalmology. 2019;126(1):113\u201324.","journal-title":"Ophthalmology"},{"issue":"2","key":"4465_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-Year clinical trial on Atropine for the treatment of myopia 2: myopia control with Atropine 0.01% Eyedrops. Ophthalmology. 2016;123(2):391\u20139.","journal-title":"Ophthalmology"},{"issue":"1","key":"4465_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12886-020-01746-w","volume":"20","author":"C Zhao","year":"2020","unstructured":"Zhao C, Cai C, Ding Q, Dai H. Efficacy and safety of Atropine to control myopia progression: a systematic review and meta-analysis. BMC Ophthalmol. 2020;20(1):478.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"4465_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, et al. Efficacy comparison of 16 interventions for myopia control in children: A network Meta-analysis. Ophthalmology. 2016;123(4):697\u2013708.","journal-title":"Ophthalmology"},{"issue":"3","key":"4465_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","volume":"129","author":"A Ha","year":"2022","unstructured":"Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and safety of 8 Atropine concentrations for myopia control in children: A network Meta-Analysis. Ophthalmology. 2022;129(3):322\u201333.","journal-title":"Ophthalmology"},{"key":"4465_CR8","doi-asserted-by":"publisher","first-page":"4274572","DOI":"10.1155\/2021\/4274572","volume":"2021","author":"C Chen","year":"2021","unstructured":"Chen C, Yao J. Efficacy and adverse effects of Atropine for myopia control in children: A Meta-Analysis of randomised controlled trials. J Ophthalmol. 2021;2021:4274572.","journal-title":"J Ophthalmol"},{"issue":"6","key":"4465_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","volume":"135","author":"Q Gong","year":"2017","unstructured":"Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G, et al. Efficacy and adverse effects of Atropine in childhood myopia: A Meta-analysis. JAMA Ophthalmol. 2017;135(6):624\u201330.","journal-title":"JAMA Ophthalmol"},{"key":"4465_CR10","doi-asserted-by":"publisher","first-page":"5125243","DOI":"10.1155\/2020\/5125243","volume":"2020","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Huang XB, Cai Q, Li JJ, Xiong YJ, Gong YX, et al. Comparative study of the effects of 1% Atropine on the anterior segment. J Ophthalmol. 2020;2020:5125243.","journal-title":"J Ophthalmol"},{"issue":"2","key":"4465_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","volume":"66","author":"MS Sridhar","year":"2018","unstructured":"Sridhar MS. Anatomy of cornea and ocular surface. Indian J Ophthalmol. 2018;66(2):190\u20134.","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"4465_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/ICO.0000000000001909","volume":"38","author":"A Vega-Estrada","year":"2019","unstructured":"Vega-Estrada A, Alio JL. Keratoconus corneal posterior surface characterization according to the degree of visual limitation. Cornea. 2019;38(6):730\u20136.","journal-title":"Cornea"},{"issue":"1","key":"4465_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10792-025-03669-1","volume":"45","author":"MA Kolaib","year":"2025","unstructured":"Kolaib MA, Mahmoud S, Ghaith AA, et al. Effect of posterior corneal surface abnormalities after deep anterior lamellar keratoplasty on visual outcomes and high order aberrations. Int Ophthalmol. 2025;45(1):301.","journal-title":"Int Ophthalmol"},{"issue":"11","key":"4465_CR14","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/j.ophtha.2020.11.016","volume":"128","author":"S Goto","year":"2021","unstructured":"Goto S, Maeda N. Corneal topography for intraocular lens selection in refractive cataract surgery. Ophthalmology. 2021;128(11):e142\u201352.","journal-title":"Ophthalmology"},{"issue":"14","key":"4465_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.61.14.15","volume":"61","author":"L Ye","year":"2020","unstructured":"Ye L, Shi Y, Yin Y, Li S, He J, Zhu J, et al. Effects of Atropine treatment on choroidal thickness in myopic children. Invest Ophthalmol Vis Sci. 2020;61(14):15.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4465_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s40123-022-00572-1","volume":"11","author":"L Ye","year":"2022","unstructured":"Ye L, Xu H, Shi Y, Yin Y, Yu T, Peng Y, et al. Efficacy and safety of consecutive use of 1% and 0.01% Atropine for myopia control in Chinese children: the Atropine for children and adolescent myopia progression study. Ophthalmol Ther. 2022;11(6):2197\u2013210.","journal-title":"Ophthalmol Ther"},{"issue":"9","key":"4465_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/OPX.0000000000000339","volume":"91","author":"HC Cheng","year":"2014","unstructured":"Cheng HC, Hsieh YT. Short-term refractive change and ocular parameter changes after cycloplegia. Optom Vis Sci. 2014;91(9):1113\u20137.","journal-title":"Optom Vis Sci"},{"key":"4465_CR18","doi-asserted-by":"crossref","unstructured":"Chang SW, Lo AY, Su PF. Anterior segment biometry changes with cycloplegia in myopic adults. Optom Vis Sci. 2016;93(1):12\u20138.","DOI":"10.1097\/OPX.0000000000000748"},{"issue":"3","key":"4465_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0021-5155(02)00479-3","volume":"46","author":"L Gao","year":"2002","unstructured":"Gao L, Zhuo X, Kwok AK, Yu N, Ma L, Wang J. The change in ocular refractive components after cycloplegia in children. Jpn J Ophthalmol. 2002;46(3):293\u20138.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"4465_CR20","doi-asserted-by":"publisher","first-page":"22470","DOI":"10.1038\/s41598-022-25462-1","volume":"12","author":"Y Tao","year":"2022","unstructured":"Tao Y, Cheng X, Ouyang C, Qu X, Liao W, Zhou Q, et al. Changes in ocular biological parameters after cycloplegia based on dioptre, age and sex. Sci Rep. 2022;12(1):22470.","journal-title":"Sci Rep"},{"issue":"5","key":"4465_CR21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jcrs.2003.10.040","volume":"30","author":"K Saitoh","year":"2004","unstructured":"Saitoh K, Yoshida K, Hamatsu Y, Tazawa Y. Changes in the shape of the anterior and posterior corneal surfaces caused by mydriasis and miosis: detailed analysis. J Cataract Refract Surg. 2004;30(5):1024\u201330.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"4465_CR22","first-page":"111","volume":"10","author":"MC Ho","year":"2019","unstructured":"Ho MC, Hsieh YT, Shen EP, Hsu WC, Cheng HC. Short-term refractive and ocular parameter changes after topical Atropine. Taiwan J Ophthalmol. 2019;10(2):111\u20135.","journal-title":"Taiwan J Ophthalmol"},{"issue":"12","key":"4465_CR23","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.ophtha.2020.06.004","volume":"127","author":"FF Li","year":"2020","unstructured":"Li FF, Kam KW, Zhang Y, Tang SM, Young AL, Chen LJ, et al. Differential effects on ocular biometrics by 0.05%, 0.025%, and 0.01% atropine: Low-Concentration Atropine for myopia progression study. Ophthalmology. 2020;127(12):1603\u201311.","journal-title":"Ophthalmology"},{"issue":"9","key":"4465_CR24","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1167\/iovs.14-14716","volume":"56","author":"A Kumaran","year":"2015","unstructured":"Kumaran A, Htoon HM, Tan D, Chia A. Analysis of changes in refraction and biometry of Atropine- and Placebo-Treated eyes. Invest Ophthalmol Vis Sci. 2015;56(9):5650\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4465_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12886-022-02385-z","volume":"22","author":"M Wang","year":"2022","unstructured":"Wang M, Cui C, Sui Y, Yu SA, Ma JX, Fu AC. Effect of 0.02% and 0.01% Atropine on astigmatism: a two-year clinical trial. BMC Ophthalmol. 2022;22(1):161.","journal-title":"BMC Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04465-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04465-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04465-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:04:48Z","timestamp":1763507088000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04465-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4465"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04465-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki, and written informed consent was obtained from the participants and their parents or guardians. The study protocol was approved by the Ethics Committee of Shanghai General People\u2019s Hospital, Shanghai, China (Approval number: 201939).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript version to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}